Professional Documents
Culture Documents
Professional Issues - Case Study 1
Professional Issues - Case Study 1
Professional Issues - Case Study 1
Benjamin Smith
DOS 518: Professional Issues
October 12, 2020
Within the field of radiation oncology, there are many quality assurance procedures
manifested to assure the patient is treated accurately and safely. However, there are many
treatment errors that still occur which are documented and submitted for review. The
organizations ASTRO and AAPM formed a national reporting system known as the ROILS
System which highlights several incidences where a radiation treatment error has occurred.
For the ROILS case study I am reviewing, we are given the following scenario involving
the wrong fractionation/prescription used for treatment. The physician verbally told the
dosimetrist to create a plan for a total dose of 3600 cGy. The dosimetrist proceeded to enter the
prescription in the patient’s electronic medical record (EMR) for 180 cGy x 20 fractions = 3600
cGy. This was not what the physician had intended as the correct prescription was 300 cGy x 12
= 3600 cGy. Nevertheless, the plan with the incorrect fractionation was approved by the
physician with the radiation therapy treatment implemented for several days before being caught
by the physician after noticing the lack of tumor regression during a weekly clinical visit.
There are several factors that need to be addressed that led to this treatment error. The
primary issue is the dosimetrist entering the prescription for the patient in their EMR. Part of the
radiation oncologist’s designated responsibilities include documenting the total desired dose and
fractionation along with treatment technique, energy, pre-treatment imaging requests as well as
any other details regarding the patient’s prescription.1 At my clinical facility, the attending
physicians not only fill out the sim intent for each patient but also utilize the “Prescribe
Treatment” page in ARIA to create a draft of the prescription they have designated for that
2
specific patient. The dosimetrists do not begin planning until the physician has filled out the
prescription tab. After the dosimetrist has created a treatment plan, he or she reviews it with the
attending physician. If the plan is verbally approved, the physician will proceed to manually
approve/sign the prescription. The reason why they do not approve the prescription from the start
is the chance the energy(ies) or treatment technique have changed from their original intent. The
draft of the prescription can be amended to account for energy or treatment technique changes
before final approval. This process may seem superfluous but it helps prevent any prescription
Due to the fact that this treatment error was not caught until a week into treatment, it is
safe to assume that physics also did their QA check on the plan as well. This pretreatment QA is
required for safe and high-quality radiation therapy for the patients.2 In this instance, they did not
catch this error which also could have prevented the patient from being mistreated. This
secondary check by the physicist includes completely reviewing the physician-approved plan,
identifying any errors after analyzing the dose distribution to the targets and critical structures as
well as other checks.2 In this particular case, it may prove difficult for the physicist to identify
the prescription error if the physician approved the plan with the wrong entered prescription and
the plan matches accordingly. At my clinical facility, our team of physicists review each
treatment plan with a fine-toothed comb which may seem tedious at times but ensures that the
Lastly, I wanted to discuss another important element that could have prevented this
treatment error. Peer review is imperative in the field of radiation oncology as it allows a 2nd or
3rd set of eyes to gauge the plan and voice any concerns. Peer review can involve any of the
oncology clinical team), and multidisciplinary (with other specialties).2 Peer review is important
for the safe delivery of radiation but even more crucial is the timing of peer review.2 Peer review
should be held prior to the treatment of the patients; therefore, appropriate measures can be taken
prior to treatment to correct any issues that may arise. Had a prospective peer review occurred
for this case of interest, either the attending physician would have seen the wrong prescription
being presented or another physician may have questioned it. At my clinical facility, peer review
is conducted 3 days a week in order to have every case presented prior to the start of their
radiation treatment. The dosimetrists upload a PDF file of the treatment plan highlighting
everything from the diagnosis, prescription with fractionation, target volumes and dose
outcomes. The dosimetrists also document which cases were sent to peer review as well as
The treatment error in this case study could have easily been avoided had the attending
physician manually entered a prescription in the patient’s chart and not the dosimetrist taking
that duty upon his/herself as that is not part of their job description. The secondary checks by the
physicist could have also caught this error but would have been more challenging. Finally, peer
review of the case prior to treatment would have allowed the attending physician and other
faculty to question the entered prescription which would have enabled the plan to be corrected
References
1. Ezzell G, Chera B, Dicker A, et al. Common error pathways seen in the RO-ILS data that
demonstrate opportunities for improving treatment safety. Pract Radiat Oncol.
2018;8(2):123-132. http://doi.org/10.1016/j.prro.2017.10.007
2. American Society for Radiation Oncology (ASTRO). Safety is No Accident- a
framework for quality radiation oncology care. ASTRO website.
https://www.astro.org/ASTRO/media/ASTRO/Patient%20Care%20and
%20Research/PDFs/Safety_is_No_Accident.pdf. Published 2019. Accessed October 7,
2020.